Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-27
DOI
10.3389/fphar.2020.01282
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
- (2019) Luca Antonioli et al. PHARMACOLOGICAL REVIEWS
- Purinergic Signaling in Pulmonary Inflammation
- (2019) Thanh-Thuy T. Le et al. Frontiers in Immunology
- The therapeutic potential of purinergic signalling
- (2018) Geoffrey Burnstock BIOCHEMICAL PHARMACOLOGY
- Extracellular ATP signaling and clinical relevance
- (2018) Lei Dou et al. CLINICAL IMMUNOLOGY
- Schiff bases of tryptamine as potent inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): Structure-activity relationship
- (2018) Kanwal et al. BIOORGANIC CHEMISTRY
- Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor
- (2017) Muhammad Rafehi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor
- (2017) Muhammad Rafehi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Generation and characterization of polyclonal and monoclonal antibodies to human NTPDase2 including a blocking antibody
- (2017) Julie Pelletier et al. Purinergic Signalling
- Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors
- (2017) Sang-Yong Lee et al. MedChemComm
- Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila
- (2016) Amelie Fiene et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins
- (2016) Younis Baqi DRUG DISCOVERY TODAY
- Ullmann reactions of 1-amino-4-bromoanthraquinones bearing various 2-substituents furnishing novel dyes
- (2016) Enas M. Malik et al. DYES AND PIGMENTS
- Expression of ecto-nucleoside triphosphate diphosphohydrolase3 (NTPDase3) in the female rat brain during postnatal development
- (2016) Ivana Grković et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Anthraquinones As Pharmacological Tools and Drugs
- (2016) Enas M. Malik et al. MEDICINAL RESEARCH REVIEWS
- Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity
- (2015) Amelie Fiene et al. ANALYST
- Inhibition of Alkaline Phosphatase: An Emerging New Drug Target
- (2015) Mariya Rashida et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Ecto-Nucleotidase Inhibitors: Recent Developments in Drug Discovery
- (2015) Younis Baqi MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071
- (2014) Matthias Zebisch et al. JOURNAL OF STRUCTURAL BIOLOGY
- NTPDase2 and Purinergic Signaling Control Progenitor Cell Proliferation in Neurogenic Niches of the Adult Mouse Brain
- (2014) Kristine Gampe et al. STEM CELLS
- 8-BuS-ATP derivatives as specific NTPDase1 inhibitors
- (2013) Joanna Lecka et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ectonucleotidases and Nucleotide/Nucleoside Transporters as Pharmacological Targets for Neurological Disorders
- (2012) Carla D. Bonan CNS & Neurological Disorders-Drug Targets
- The medial habenula contains a specific nonstellate subtype of astrocyte expressing the ectonucleotidase NTPDase2
- (2012) Kristine Gampe et al. GLIA
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- Efficient and mild deamination procedure for 1-aminoanthraquinones yielding a diverse library of novel derivatives with potential biological activity
- (2012) Younis Baqi et al. TETRAHEDRON LETTERS
- Discovery of Potent Competitive Antagonists and Positive Modulators of the P2X2 Receptor
- (2011) Younis Baqi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Potent and Selective Inhibitors ofecto-5′-Nucleotidase Based on an Anthraquinone Scaffold
- (2010) Younis Baqi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions
- (2010) Younis Baqi et al. Nature Protocols
- High-Affinity, Non-Nucleotide-Derived Competitive Antagonists of Platelet P2Y12Receptors
- (2009) Younis Baqi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3
- (2008) Mercedes N. Munkonda et al. FEBS Journal
- Selective Nucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2) Inhibitors: Nucleotide Mimetics Derived from Uridine-5′-carboxamide†
- (2008) Andreas Brunschweiger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)
- (2008) Younis Baqi et al. Purinergic Signalling
- Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists
- (2007) Stefanie Weyler et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started